244 results
8-K
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
Business Officer from January 2019 to January 2020, Senior Vice President, Business Development and Strategy from November 2017 to December 2018 and as Vice … President, Strategy from February 2016 to November 2017, where he helped to initiate and execute on several transformative partnerships, establish
8-K
EX-99.4
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
from their condition. Oruka’s strategy is to apply antibody engineering and format innovations to validated modes of action, which Oruka believes … focused strategy, differentiated portfolio, and deep expertise position it to set a new treatment standard in large I&I markets with continued unmet need
8-K
EX-3.6
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
supervision and direction of the business and affairs of the Corporation, shall be responsible for corporate policy and strategy, and shall report
425
EX-99.1
ORKA
Oruka Therapeutics Inc.
26 Aug 24
Business combination disclosure
7:53pm
; the nature, strategy and focus of the combined company; the development and commercial potential and potential benefits of any product candidates
425
ORKA
Oruka Therapeutics Inc.
26 Aug 24
Business combination disclosure
7:53pm
; the future operations of the combined company; the nature, strategy and focus of the combined company; the development and commercial potential
8-K
1nhhd3yr
26 Aug 24
ARCA biopharma Provides Update Regarding Special Dividend Amount in Connection with the Proposed Merger with Oruka Therapeutics
7:51pm
8-K
EX-99.1
ljh z5hf357k
26 Aug 24
ARCA biopharma Provides Update Regarding Special Dividend Amount in Connection with the Proposed Merger with Oruka Therapeutics
7:51pm
8-K
EX-99.1
d8iyzlgdfw25
23 Aug 24
ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka Therapeutics
4:35pm
8-K
1yk rqbx9cjogu
23 Aug 24
ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka Therapeutics
4:35pm
425
fr9lx4o
16 Aug 24
Business combination disclosure
4:27pm
425
EX-99.1
bkhuhr3ondqt0 tb
16 Aug 24
Business combination disclosure
4:27pm
8-K
si656eo mork9
16 Aug 24
ARCA biopharma Declares Special Dividend in Connection with the Proposed Merger with Oruka Therapeutics
4:25pm
8-K
EX-99.1
meg4 ii42mm6zu47
16 Aug 24
ARCA biopharma Declares Special Dividend in Connection with the Proposed Merger with Oruka Therapeutics
4:25pm
425
b6kb7eskwzp2sga
15 Aug 24
Business combination disclosure
4:17pm
8-K
ko0vd
15 Aug 24
Entry into a Material Definitive Agreement
4:15pm
425
qrg 2gdhz
9 Aug 24
Business combination disclosure
8:35am
424B3
iybneozl6jkub 0xb
1 Aug 24
Prospectus supplement
4:10pm